Idex Corporation · NYSE:IEX

Idex — Q1 2019 Earnings Presentation

9 slides from Idex's earnings presentation, Apr 26, 2019

  1. Slide 1: First Quarter 2019 Earnings

    First Quarter 2019 Earnings April 26, 2019 IDEX Proprietary & Confidential

  2. Slide 2: Agenda

    AGENDA • IDEX’s Overview and Outlook • Q1 Financial Performance • Segment Performance • Fluid & Metering Technologies • Health & Science Technologies • Fire & Safety / Diversified Products • 2019 Guidance Summary • Q&A Brand names shown in this presentation are registered trademarks of IDEX Corporat

  3. Slide 3: Replay Information

    Replay Information • Dial toll–free: 877.660.6853 • International: 201.612.7415 • Conference ID: #13684162 • Log on to: www.idexcorp.com Brand names shown in this presentation are registered trademarks of IDEX Corporation and/or its subsidiaries IDEX Proprietary & Confidential 2

  4. Slide 4: Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures

    Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation and discussion will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other thin

  5. Slide 5: IDEX Q1 Financial Performance

    IDEX Q1 Financial Performance (Dollars in millions, excl. EPS) Sales EPS* 12% increase Organic: 4% increase $1.29 $1.44 $612 $622 $1.50 $700 $1.00 $500 $0.50 $300 $0.00 Q1 Q1 2018 2019 2018 2019 Operating Margin* Free Cash Flow 120 bps increase 23% increase 23.8% $76 26.0% 22.6% $90 $62 24.0% 22.0%

  6. Slide 6: Fluid & Metering Technologies

    Fluid & Metering Technologies (Dollars in millions) Orders Sales Operating Margin* Organic: 10% increase Organic: 6% increase 110 bps increase $243 $238 $256 $232 29.6% $300 28.5% $300 30.0% $200 $200 28.0% $100 $100 26.0% $0 $0 24.0% Q1 Q1 Q1 2018 2019 2018 2019 2018 2019 Q1 Sales Mix: Organic 6% Q

  7. Slide 7: Health & Science Technologies

    Health & Science Technologies (Dollars in millions) Orders Sales Operating Margin* Organic: 1% increase Organic: 3% increase 10 bps increase $240 $240 $221 $225 $250 $250 26.0% 23.9% 24.0% $200 $200 24.0% $150 $150 22.0% $100 $100 20.0% Q1 Q1 Q1 2018 2019 2018 2019 2018 2019 Q1 Sales Mix: Organic 3%

  8. Slide 8: Fire & Safety / Diversified Products

    Fire & Safety / Diversified Products (Dollars in millions) Orders Sales Operating Margin* Organic: 9% increase Organic: 1% increase 90 bps increase $162 $159 $156 $154 $200 30.0% $200 24.9% 25.8% $150 $150 25.0% $100 $100 20.0% $50 $50 Q1 Q1 Q1 2018 2019 2018 2019 2018 2019 Q1 Sales Mix: Organic 1%

  9. Slide 9: 2019 Guidance Summary

    2019 Guidance Summary Q2 2019 – EPS estimate range: $1.47 – $1.50 – Organic revenue growth: 4 – 5% – Operating margin: ~24.0% – Tax rate: ~22.5% – FX impact: ~2.0% topline headwind based on March 31, 2019 FX rates – Corporate costs: ~$20 million FY 2019 – EPS estimate range: $5.70 – $5.85 – Organic

Idex — Q1 2019 Earnings Presentation on 6ix